1,028 research outputs found
a follow-up on bone graft stability and implant success
Background Until now, sinus floor elevation represents the gold standard
procedure in the atrophic maxilla in order to facilitate dental implant
insertion. Although the procedure remains highly predictive, the perforation
of the Schneiderian membrane might compromise the stability of the augmented
bone and implant success due to chronic sinus infection. The aim of this
retrospective cohort study was to show that a membrane tear, if detected and
surgically properly addressed, has no influence on the survival of dental
implants and bone resorption in the augmented area. Methods Thirty-one
patients with 39 perforations could be included in this evaluation, and a
control group of 32 patients with 40 sinus lift procedures without
complications were compared regarding the radiographically determined
development of bone level, peri-implant infection, and implant loss. Results
Implant survival was 98.9% in the perforation group over an observation period
of 2.7 (± 2.03) years compared to 100% in the control group after 1.8 (± 1.57)
years. The residual bone level was significantly lower in the perforation
group (p = 0.05) but showed no difference direct postoperatively (p = 0.7851)
or in the follow-up assessment (p = 0.2338). Bone resorption remained not
different between both groups (p = 0.945). A two-stage procedure was more
frequent in the perforation group (p = 0.0003) as well as peri-implantitis (p
= 0.0004). Conclusions Within the limits of our study, the perforation of the
Schneiderian membrane did not have a negative impact on long-term graft
stability or the overall implant survival
Realistic description of electron-energy loss spectroscopy for One-Dimensional SrCuO
We investigate the electron-energy loss spectrum of one-dimensional undoped
CuO chains within an extended multi-band Hubbard model and an extended
one-band Hubbard model, using the standard Lanczos algorithm. Short-range
intersite Coulomb interactions are explicitly included in these models, and
long-range interactions are treated in random-phase approximation. The results
for the multi-band model with standard parameter values agree very well with
experimental spectra of SrCuO. In particular, the width of the main
structure is correctly reproduced for all values of momentum transfer. It is
shown for both models that intersite Coulomb interactions mainly lead to an
energy shift of the spectra. We find no evidence for enhanced intersite
interactions in SrCuO.Comment: 4 pages, 4 figure
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
The taxonomy of the family Filoviridae (marburgviruses and ebolaviruses) has changed several times since the discovery of its members, resulting in a plethora of species and virus names and abbreviations. The current taxonomy has only been partially accepted by most laboratory virologists. Confusion likely arose for several reasons: species names that consist of several words or which (should) contain diacritical marks, the current orthographic identity of species and virus names, and the similar pronunciation of several virus abbreviations in the absence of guidance for the correct use of vernacular names. To rectify this problem, we suggest (1) to retain the current species names Reston ebolavirus, Sudan ebolavirus, and Zaire ebolavirus, but to replace the name Cote d'Ivoire ebolavirus [sic] with Taï Forest ebolavirus and Lake Victoria marburgvirus with Marburg marburgvirus; (2) to revert the virus names of the type marburgviruses and ebolaviruses to those used for decades in the field (Marburg virus instead of Lake Victoria marburgvirus and Ebola virus instead of Zaire ebolavirus); (3) to introduce names for the remaining viruses reminiscent of jargon used by laboratory virologists but nevertheless different from species names (Reston virus, Sudan virus, Taï Forest virus), and (4) to introduce distinct abbreviations for the individual viruses (RESTV for Reston virus, SUDV for Sudan virus, and TAFV for Taï Forest virus), while retaining that for Marburg virus (MARV) and reintroducing that used over decades for Ebola virus (EBOV). Paying tribute to developments in the field, we propose (a) to create a new ebolavirus species (Bundibugyo ebolavirus) for one member virus (Bundibugyo virus, BDBV); (b) to assign a second virus to the species Marburg marburgvirus (Ravn virus, RAVV) for better reflection of now available high-resolution phylogeny; and (c) to create a new tentative genus (Cuevavirus) with one tentative species (Lloviu cuevavirus) for the recently discovered Lloviu virus (LLOV). Furthermore, we explain the etymological derivation of individual names, their pronunciation, and their correct use, and we elaborate on demarcation criteria for each taxon and virus.S
Norovirus Transmission on Cruise Ship
We documented transmission by food and person-to-person contact; persistence of virus despite sanitization onboard, including introductions of new strains; and seeding of an outbreak on land
Management of giant-cell arteritis in Switzerland: an online national survey.
AIMS OF THE STUDY
To assess current practices in diagnosing, treating, and following-up giant-cell arteritis by specialists in Switzerland and to identify the main barriers to using diagnostic tools.
METHODS
We performed a national survey of specialists potentially caring for patients with giant-cell arteritis. The survey was sent by email to all members of the Swiss Societies of Rheumatology and for Allergy and Immunology. A reminder was sent to nonresponders after 4 and 12 weeks. Its questions covered the following dimensions: respondents' main characteristics, diagnosis, treatment, and imaging's role during follow-up. The main study results were summarized using descriptive statistics.
RESULTS
Ninety-one specialists, primarily aged 46-65 years (n = 53/89; 59%), working in academic or nonacademic hospitals or private practice, and treating a median of 7.5 (interquartile range [IQR]: 3-12) patients with giant-cell arteritis per year participated in this survey. Ultrasound of temporal arteries/large vessels (n = 75/90; 83%) and positron-emission-tomography-computed tomography (n = 52/91; 57%) or magnetic resonance imaging (n = 46/90; 51%) of the aorta/extracranial arteries were the most common techniques used to diagnose giant-cell arteritis with cranial or large vessel involvement, respectively. Most participants reported a short time to obtain imaging tests or arterial biopsy. The glucocorticoid tapering scheme, glucocorticoid-sparing agent, and glucocorticoid-sparing treatment duration varied among the participants. Most physicians did not follow a predefined repeat imaging scheme for follow-up and mainly relied on structural changes (vascular thickening, stenosis, or dilatation) to drive treatment choice.
CONCLUSIONS
This survey indicates that imaging and temporal biopsy are rapidly accessible for diagnosing giant-cell arteritis in Switzerland but highlights heterogeneous practice in many disease management areas
Clinical Efficacy of Blue Light Full Body Irradiation as Treatment Option for Severe Atopic Dermatitis
BACKGROUND: Therapy of atopic dermatitis (AD) relies on immunosuppression and/or UV irradiation. Here, we assessed clinical efficacy and histopathological alterations induced by blue light-treatment of AD within an observational, non-interventional study. METHODOLOGY/PRINCIPAL FINDINGS: 36 patients with severe, chronic AD resisting long term disease control with local corticosteroids were included. Treatment consisted of one cycle of 5 consecutive blue light-irradiations (28.9 J/cm(2)). Patients were instructed to ask for treatment upon disease exacerbation despite interval therapy with topical corticosteroids. The majority of patients noted first improvements after 2-3 cycles. The EASI score was improved by 41% and 54% after 3 and 6 months, respectively (p≤0.005, and p≤0.002). Significant improvement of pruritus, sleep and life quality was noted especially after 6 months. Also, frequency and intensity of disease exacerbations and the usage of topical corticosteroids was reduced. Finally, immunohistochemistry of skin biopsies obtained at baseline and after 5 and 15 days revealed that, unlike UV light, blue light-treatment did not induce Langerhans cell or T cell depletion from skin. CONCLUSIONS/SIGNIFICANCE: Blue light-irradiation may represent a suitable treatment option for AD providing long term control of disease. Future studies with larger patient cohorts within a randomized, placebo-controlled clinical trial are required to confirm this observation
Establishment of Fruit Bat Cells (Rousettus aegyptiacus) as a Model System for the Investigation of Filoviral Infection
Marburg virus and several species of Ebola virus are endemic in central Africa and cause sporadic outbreaks in this region with mortality rates of up to 90%. So far, there is no vaccination or therapy available to protect people at risk in these regions. Recently, different fruit bats have been identified as potential reservoirs. One of them is Rousettus aegyptiacus. It seems that within huge bat populations only relatively small numbers are positive for filovirus-specific antibodies or filoviral RNA, a phenomenon that is currently not understood. As a first step towards understanding the biology of filoviruses in bats, we sought to establish a model system to investigate filovirus replication in cells derived from their natural reservoir. Here, we provide the first insights into this topic by monitoring filovirus infection of a Rousettus aegyptiacus derived cell line, R06E. We were able to show that filoviruses propagate well in R06E cells, which can, therefore, be used to investigate replication and transcription of filovirus RNA and to very efficiently perform rescue of recombinant Marburg virus using reverse genetics. These results emphasize the suitability of the newly established bat cell line for filovirus research
Epizootic Emergence of Usutu Virus in Wild and Captive Birds in Germany
This study aimed to identify the causative agent of mass mortality in wild and captive birds in southwest Germany and to gather insights into the phylogenetic relationship and spatial distribution of the pathogen. Since June 2011, 223 dead birds were collected and tested for the presence of viral pathogens. Usutu virus (USUV) RNA was detected by real-time RT-PCR in 86 birds representing 6 species. The virus was isolated in cell culture from the heart of 18 Blackbirds (Turdus merula). USUV-specific antigen was demonstrated by immunohistochemistry in brain, heart, liver, and lung of infected Blackbirds. The complete polyprotein coding sequence was obtained by deep sequencing of liver and spleen samples of a dead Blackbird from Mannheim (BH65/11-02-03). Phylogenetic analysis of the German USUV strain BH65/11-02-03 revealed a close relationship with strain Vienna that caused mass mortality among birds in Austria in 2001. Wild birds from lowland river valleys in southwest Germany were mainly affected by USUV, but also birds kept in aviaries. Our data suggest that after the initial detection of USUV in German mosquitoes in 2010, the virus spread in 2011 and caused epizootics among wild and captive birds in southwest Germany. The data also indicate an increased risk of USUV infections in humans in Germany
a randomized, placebo-controlled phase II AIO trial with serum biomarker program
Background As a multi-targeted anti-angiogenic receptor tyrosine kinase (RTK)
inhibitor sunitinib (SUN) has been established for renal cancer and
gastrointestinal stromal tumors. In advanced refractory esophagogastric cancer
patients, monotherapy with SUN was associated with good tolerability but
limited tumor response. Methods This double-blind, placebo-controlled,
multicenter, phase II clinical trial was conducted to evaluate the efficacy,
safety and tolerability of SUN as an adjunct to second and third-line FOLFIRI
(NCT01020630). Patients were randomized to receive 6-week cycles including
FOLFIRI plus sodium folinate (Na-FOLFIRI) once every two weeks and SUN or
placebo (PL) continuously for four weeks followed by a 2-week rest period. The
primary study endpoint was progression-free survival (PFS). Preplanned serum
analyses of VEGF-A, VEGF-D, VEGFR2 and SDF-1α were performed retrospectively.
Results Overall, 91 patients were randomized, 45 in each group (one patient
withdrew). The main grade ≥3 AEs were neutropenia and leucopenia, observed in
56 %/20 % and 27 %/16 % for FOLFIRI + SUN/FOLFIRI + PL, respectively. Median
PFS was similar, 3.5 vs. 3.3 months (hazard ratio (HR) 1.11, 95 % CI
0.70–1.74, P = 0.66) for FOLFIRI + SUN vs. FOLFIRI + PL, respectively. For
FOLFIRI + SUN, a trend towards longer median overall survival (OS) compared
with placebo was observed (10.4 vs. 8.9 months, HR 0.82, 95 % CI 0.50–1.34,
one-sided P = 0.21). In subgroup serum analyses, significant changes in VEGF-A
(P = 0.017), VEGFR2 (P = 0.012) and VEGF-D (P < 0.001) serum levels were
observed. Conclusions Although sunitinib combined with FOLFIRI did not improve
PFS and response in chemotherapy-resistant gastric cancer, a trend towards
better OS was observed. Further biomarker-driven studies with other anti-
angiogenic RTK inhibitors are warranted. Trial registration This study was
registered prospectively in the NCT Clinical Trials Registry
(ClinicalTrials.gov) under NCT01020630 on November 23, 2009 after approval by
the leading ethics committee of the Medical Association of Rhineland-
Palatinate, Mainz, in coordination with the participating ethics committees
(see Additional file 2) on September 16, 2009
Recommended from our members
Molecular Diagnostics for Lassa Fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons Learnt from Two Years of Laboratory Operation
Background: Lassa fever is a viral hemorrhagic fever endemic in West Africa. However, none of the hospitals in the endemic areas of Nigeria has the capacity to perform Lassa virus diagnostics. Case identification and management solely relies on non-specific clinical criteria. The Irrua Specialist Teaching Hospital (ISTH) in the central senatorial district of Edo State struggled with this challenge for many years. Methodology/Principal Findings A laboratory for molecular diagnosis of Lassa fever, complying with basic standards of diagnostic PCR facilities, was established at ISTH in 2008. During 2009 through 2010, samples of 1,650 suspected cases were processed, of which 198 (12%) tested positive by Lassa virus RT-PCR. No remarkable demographic differences were observed between PCR-positive and negative patients. The case fatality rate for Lassa fever was 31%. Nearly two thirds of confirmed cases attended the emergency departments of ISTH. The time window for therapeutic intervention was extremely short, as 50% of the fatal cases died within 2 days of hospitalization—often before ribavirin treatment could be commenced. Fatal Lassa fever cases were older (p = 0.005), had lower body temperature (p<0.0001), and had higher creatinine (p<0.0001) and blood urea levels (p<0.0001) than survivors. Lassa fever incidence in the hospital followed a seasonal pattern with a peak between November and March. Lassa virus sequences obtained from the patients originating from Edo State formed—within lineage II—a separate clade that could be further subdivided into three clusters. Conclusions/Significance: Lassa fever case management was improved at a tertiary health institution in Nigeria through establishment of a laboratory for routine diagnostics of Lassa virus. Data collected in two years of operation demonstrate that Lassa fever is a serious public health problem in Edo State and reveal new insights into the disease in hospitalized patients.Organismic and Evolutionary Biolog
- …